# A Study of Tirzepatide in Participants With Impaired Liver Function

> **NCT03940742** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 32 (actual)

## Conditions studied

- Hepatic Insufficiency

## Interventions

- **DRUG:** Tirzepatide

## Key facts

- **NCT ID:** NCT03940742
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-22
- **Primary completion:** 2020-09-22
- **Final completion:** 2020-09-22
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2023-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03940742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03940742, "A Study of Tirzepatide in Participants With Impaired Liver Function". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT03940742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*